Press release
United States Bacteremia Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Pherecydes Pharma, Baxter, Novartis AG, Venatorx Pharmaceuticals
The Global Bacteremia Market is expected to grow at a significant CAGR during the forecast period 2024-2031.Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/bacteremia-market?sg
Industry Latest News 2025:
✅ 16 Jun 2025 - bioMérieux acquired the assets of Day Zero Diagnostics (NGS-based workflows for bloodstream infection ID/AMR).
✅ 14 Jul 2025 - Waters Corporation to combine with Becton, Dickinson's Biosciences & Diagnostic Solutions business (large consolidation impacting blood-culture/diagnostics supply).
✅ 12 Jun 2025 - Reports that Thermo Fisher Scientific is exploring the sale of parts of its diagnostics business (including the microbiology unit).
✅ 15 Jan 2025 - Rapid Infection Diagnostics (RID) launched BSIDx, a "one-button" system that identifies pathogens and provides antibiotic-susceptibility results from positive blood cultures in under 5 hours.
✅ 11 Feb 2025 - FIND published an updated "Blood Culture" landscape report highlighting simplified/integrated blood-culture workflows and companies developing rapid ID/AST solutions.
✅ 17 Apr 2025 - Diasorin's company presentation referenced expansion of the LIAISON PLEX® Blood Culture portfolio (new panels/portfolio positioning for blood-culture testing).
✅ 02 Jul 2025 - NEJM published evidence comparing 7 vs 14 days antibiotic therapy for uncomplicated bloodstream infection - potential to influence stewardship and diagnostics utilization.
✅ 22 Jul 2025 - BARDA / AMR-related funding and prize activity announced with diagnostics/stewardship focus (calls and RFPs that can accelerate BSI diagnostic adoption in stewardship programs).
✅ 2025 (throughout year) - Multiple academic/clinical papers and conference posters reported advances in NGS-based, real-time sequencing and rapid phenotypic AST workflows aimed at shortening time-to-result for bloodstream infections.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/bacteremia-market?sg
Major Key Players: Pfizer, Pherecydes Pharma, Baxter, Novartis AG, Venatorx Pharmaceuticals, HAL, GSK plc, Sandoz, Basilea Pharmaceutica Ltd, Fresenius SE & Co. KGaA.
Market Growth Drivers:
✅ Rising Prevalence of Hospital-Acquired Infections:
Increased cases of catheter-associated and surgical site infections are significantly contributing to the growing incidence of bacteremia globally.
✅ Advancements in Diagnostic Technologies:
The shift from conventional culture-based methods to rapid molecular and automated diagnostic platforms is enhancing detection accuracy and reducing turnaround time.
✅ Antimicrobial Resistance (AMR):
The growing challenge of antibiotic resistance is leading to higher rates of recurrent bloodstream infections, pushing pharmaceutical innovation toward novel antibiotic classes and combination therapies.
✅ Aging Population and Immunocompromised Patients:
Expanding elderly populations and increasing numbers of immunocompromised patients (such as those undergoing chemotherapy or organ transplants) are elevating the risk of bacteremia.
✅ Government and Institutional Initiatives:
Rising global focus on infection prevention, surveillance programs, and antimicrobial stewardship initiatives by public health agencies is supporting awareness and early diagnosis efforts.
Segments Covered in the Bacteremia Market
By Type (Transient, Intermittent)
By Infection Type (Gram-positive bacterial infection, Gram-negative bacterial infection)
By Antibiotics (Beta-lactams, Glycopeptides, Aminoglycosides, Fluoroquinolones, Others)
By End User (Hospitals, Specialty Clinics, Others)
By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa)
Regional Analysis for Bacteremia Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=bacteremia-market
Chapter Outline:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Bacteremia market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Bacteremia Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Bacteremia market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Bacteremia Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Bacteremia market?
➠ Who are the global key manufacturers of the Bacteremia Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Bacteremia market opportunities and threats faced by the vendors in the global Bacteremia Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Bacteremia market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Bacteremia Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Pherecydes Pharma, Baxter, Novartis AG, Venatorx Pharmaceuticals here
News-ID: 4257443 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Polymerase Chain Reaction (PCR) Market Rapid Growt 2025-2033: Most Leading Compa …
polymerase chain reaction market size reached US$ 11.58 Billion in 2023 with a rise of US$ 12.33 Billion in 2024 and is expected to reach US$ 22.66 Billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/polymerase-chain-reaction-market?kb
United States: Recent Industry Developments
✅ November 2025: Thermo Fisher Scientific launched an ultra-fast PCR system…
Transformer Monitoring Systems Industry Trends Shaping Energy Sector | Most Lead …
DataM Intelligence has published a new research report on "Transformer Monitoring Systems Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report…
Future of Performance Elastomers Market Through 2032: Most Leading Companies - Z …
DataM Intelligence has published a new research report on "Performance Elastomer Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report (Get…
Wireless Charging Market to Reach US$ 60.7 Billion by 2031 | Strong 27.3% CAGR | …
The Global Wireless Charging Market was valued at US$ 8.9 billion in 2023 and is projected to reach US$ 60.7 billion by 2031, growing at a CAGR of 27.3% during the forecast period 2024-2031. The market is experiencing strong momentum driven by the rapid adoption of smartphones, wearables, electric vehicles, and smart home devices, all of which increasingly rely on convenient, cable-free power solutions. Expanding consumer preference for seamless charging…
More Releases for Bacteremia
Staphylococcus aureus Bacteremia (SAB) market is expected to reach USD 8.3 billi …
Staphylococcus aureus bacteremia (SAB) is a serious bloodstream infection that can lead to sepsis, endocarditis, osteomyelitis, and metastatic abscesses. It is associated with high morbidity and mortality, especially in hospitalized, immunocompromised, and device-implanted patients. Both methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) are significant drivers of hospital- and community-acquired infections.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71753
The SAB market is expanding due to rising incidence, antimicrobial…
Bacteremia Market to Reach USD 9.8 Billion by 2034
Bacteremia is a potentially life-threatening condition characterized by the presence of bacteria in the bloodstream, often resulting from infections such as pneumonia, urinary tract infections (UTIs), surgical site infections, or catheter-related infections. Left untreated, bacteremia can progress to sepsis, septic shock, and multi-organ failure.
The increasing prevalence of hospital-acquired infections (HAIs), coupled with the rise of multidrug-resistant (MDR) pathogens such as Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, has…
Bacteremia Market Witnesses Rapid Evolution as Diagnostic and Therapeutic Advanc …
The global bacteremia market is experiencing a period of dynamic expansion, fueled by rising incidence of bloodstream infections, advances in rapid diagnostic technologies, and heightened focus on antimicrobial stewardship. Bacteremia, the presence of bacteria in the bloodstream, can lead to life-threatening conditions such as sepsis if not identified and treated promptly. As healthcare systems around the world work to stem infection-related mortality and healthcare costs, innovations in diagnostics, therapeutics, and…
Bacteremia Pipeline: Emerging Therapies Set to Transform Bacteremia Treatment La …
The bacteremia treatment landscape is rapidly evolving, driven by innovative therapies from leading pharma and biotech companies targeting the complex pathogenesis of bacterial infections. Companies like XBiotech, LegoChem Biosciences, Basilea Pharmaceutica, ContraFect, Merck, and Cumberland Pharmaceuticals are at the forefront, developing novel antibiotics and immunotherapies aimed at combating multidrug-resistant (MDR) bacteria, a growing concern in the management of bacteremia. These emerging therapies seek to address the high unmet need by…
Bacteremia Market Next Big Thing | Major Giants- Novartis, Merck, Pfizer
Worldwide Bacteremia Market In-depth Research Report 2022, Forecast to 2029 is the latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities, and leveraging with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Worldwide Bacteremia Market. Some of the key players profiled in the study are Merck, Ronak Daru,…
The Bacteremia Market To Go The Telemedicine Apps Way
Bacteremia is a condition in which there is presence of viable bacteria in the blood. It may cause as a result of untreated wound, surgical procedure or infected injection. Occult bacteremia usually occurs in children. In this type, there is bacterial infection in blood, and the patient shows no symptoms other than fever. Some of the patients may have runny nose and cough.
Main causative agent of occult bacteremia is Streptococcus…
